These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21321479)

  • 21. Emerging roles of cysteine cathepsins in disease and their potential as drug targets.
    Vasiljeva O; Reinheckel T; Peters C; Turk D; Turk V; Turk B
    Curr Pharm Des; 2007; 13(4):387-403. PubMed ID: 17311556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.
    Yuan L; Zhao J; Zhao S; Dong T; Dong R; Liu D; Ma E; Li Y
    Chem Biol Interact; 2022 Feb; 353():109811. PubMed ID: 35016848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of the P1 SAR of aldehyde cathepsin K inhibitors.
    Catalano JG; Deaton DN; Furfine ES; Hassell AM; McFadyen RB; Miller AB; Miller LR; Shewchuk LM; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2004 Jan; 14(1):275-8. PubMed ID: 14684342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of selective Cathepsin inhibitors.
    Bethel PA; Gerhardt S; Jones EV; Kenny PW; Karoutchi GI; Morley AD; Oldham K; Rankine N; Augustin M; Krapp S; Simader H; Steinbacher S
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4622-5. PubMed ID: 19616430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a novel cathepsin inhibitor with dual autophagy-inducing and metastasis-inhibiting effects on breast cancer cells.
    Yuan L; Liu J; He W; Bao Y; Sheng L; Zou C; Hu B; Ge W; Liu Y; Wang J; Lin B; Li Y; Ma E
    Bioorg Chem; 2019 Mar; 84():239-253. PubMed ID: 30503850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of cathepsin activities alter or prevent the development of lung granulomas in a mouse model of sarcoidosis.
    Samokhin AO; Gauthier JY; Percival MD; Brömme D
    Respir Res; 2011 Jan; 12(1):13. PubMed ID: 21251246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex.
    Tsuge H; Nishimura T; Tada Y; Asao T; Turk D; Turk V; Katunuma N
    Biochem Biophys Res Commun; 1999 Dec; 266(2):411-6. PubMed ID: 10600517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irreversible inhibition of human cathepsins B, L, S and K by hypervalent tellurium compounds.
    Cunha RL; Gouvêa IE; Feitosa GP; Alves MF; Brömme D; Comasseto JV; Tersariol IL; Juliano L
    Biol Chem; 2009 Nov; 390(11):1205-12. PubMed ID: 19663682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.
    Jung M; Lee J; Seo HY; Lim JS; Kim EK
    PLoS One; 2015; 10(1):e0116972. PubMed ID: 25625842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.
    Kerns JK; Nie H; Bondinell W; Widdowson KL; Yamashita DS; Rahman A; Podolin PL; Carpenter DC; Jin Q; Riflade B; Dong X; Nevins N; Keller PM; Mitchell L; Tomaszek T
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4409-15. PubMed ID: 21733692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate-derived triazolo- and azapeptides as inhibitors of cathepsins K and S.
    Galibert M; Wartenberg M; Lecaille F; Saidi A; Mavel S; Joulin-Giet A; Korkmaz B; Brömme D; Aucagne V; Delmas AF; Lalmanach G
    Eur J Med Chem; 2018 Jan; 144():201-210. PubMed ID: 29272750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F.
    Frizler M; Schmitz J; Schulz-Fincke AC; Gütschow M
    J Med Chem; 2012 Jun; 55(12):5982-6. PubMed ID: 22686657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel purine nitrile derived inhibitors of the cysteine protease cathepsin K.
    Altmann E; Cowan-Jacob SW; Missbach M
    J Med Chem; 2004 Nov; 47(24):5833-6. PubMed ID: 15537340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis.
    Chen JC; Uang BJ; Lyu PC; Chang JY; Liu KJ; Kuo CC; Hsieh HP; Wang HC; Cheng CS; Chang YH; Chang MD; Chang WS; Lin CC
    J Med Chem; 2010 Jun; 53(11):4545-9. PubMed ID: 20481438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts.
    Fuller K; Lawrence KM; Ross JL; Grabowska UB; Shiroo M; Samuelsson B; Chambers TJ
    Bone; 2008 Jan; 42(1):200-11. PubMed ID: 17962093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.
    Black WC; Percival MD
    Chembiochem; 2006 Oct; 7(10):1525-35. PubMed ID: 16921579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azepanone-based inhibitors of human cathepsin L.
    Marquis RW; James I; Zeng J; Trout RE; Thompson S; Rahman A; Yamashita DS; Xie R; Ru Y; Gress CJ; Blake S; Lark MA; Hwang SM; Tomaszek T; Offen P; Head MS; Cummings MD; Veber DF
    J Med Chem; 2005 Nov; 48(22):6870-8. PubMed ID: 16250645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors.
    Wiener DK; Lee-Dutra A; Bembenek S; Nguyen S; Thurmond RL; Sun S; Karlsson L; Grice CA; Jones TK; Edwards JP
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2379-82. PubMed ID: 20188543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in micro-CT 3D bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and cortical bone formation in ovariectomized mice.
    Xiang A; Kanematsu M; Kumar S; Yamashita D; Kaise T; Kikkawa H; Asano S; Kinoshita M
    Bone; 2007 May; 40(5):1231-7. PubMed ID: 17347064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin S inhibitors: 2004-2010.
    Lee-Dutra A; Wiener DK; Sun S
    Expert Opin Ther Pat; 2011 Mar; 21(3):311-37. PubMed ID: 21342054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.